申请人:SMITHKLINE BECKMAN CORPORATION
公开号:EP0285356A3
公开(公告)日:1989-05-31
Compounds of formula (I)
in which X is H, F, Cl, Br, I, C₁₋₄alkyl, CN, NO₂, SO₂NH₂, COOH, CHO, C₁₋₄alkoxy, CH₂OH, CF₃, SO₂CH₃, SO₂CF₃ or CO₂CaH2a+1 wherein a is 1-5, or any accessible combination thereof of up to 3 substituents; R is H or C₁₋₄alkyl; and n is 1-5; or any pharmaceutically acceptable salt or hydrate thereof, processes for their preparation, intermediates useful in their preparation, pharmaceutical compositions containing them and their use in therapy as dopamine-β-hydroxylase inhibitors.
式(I)中的化合物,其中X为H,F,Cl,Br,I,C₁₋₄烷基,CN,NO₂,SO₂NH₂,COOH,CHO,C₁₋₄烷氧基,CH₂OH,CF₃,SO₂CH₃,SO₂CF₃或CO₂CaH2a+1,其中a为1-5,或最多3个取代基的任意组合;R为H或C₁₋₄烷基;n为1-5;或其任何药用可接受的盐或水合物,其制备方法,制备中有用的中间体,含有它们的药物组合物以及它们在治疗中作为多巴胺-β-羟化酶抑制剂的用途。